19
Participants
Start Date
February 12, 2020
Primary Completion Date
April 25, 2024
Study Completion Date
April 25, 2024
carbidopa/levodopa, as prescribed by treating physician
"There will be 4 measurement states:~at baseline prior to chronic treatment initiation (OFF-No LDR); at baseline after a standard, acute oral dose (25/250 carbidopa/L-dopa), referenced in the protocol, but prescribed and provided by their prescribing physician as standard of care initial dosage (ON-No LDR); 2 months after initiation of chronic, stable L-dopa treatment (amounts and sequences as prescribed by treating physicians) but with no L-dopa for 10-12 hours prior to evaluation (Practical OFF- LDR); and after resuming subjects' usual physician-prescribed L-dopa dose (ON-LDR)."
University of Michigan, Ann Arbor
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
University of Michigan
OTHER